Fundamental Analysis of Medpace Holdings Inc - Growth / Value Index


MEDP - Valuation Highlights

Valuation Analysis

   Undervalued - Price to Intrinsic Value of 0.0198
   Price to Book Ratio of 25.62 suggesting that it is very expensive
Valuation Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Price to Earning 39.30 45.03 -15.06 %
Price to Book 25.17 22.01 -34.63 % 18.41
Price to Sales 6.26 6.90 -22.50 %
Enterprise Value to EBITDA Multiple 11.72 41.38 -3.22 %


MEDP - Profitability Highlights

Profitability Analysis

   Tsr Profitability Index - Good Score of 68.75
   Piotroski F Score - Good Value of 7.0
   Tremendous increasing trend in Net Profit for last 3 year
   Excellent QoQ /QoQ FY EPS growth
   Strong Return On Capital Employed of 48.87
   Company Earning excess return
   During the past twelve months, the company has given a strong Return On Equity of 64.05%
   During the past twelve months, the company has given a strong Return On Asset of 20.18%
   All key Trailing Twelve Months Margin growing by 15 %
   Company's Net Profit is increasing for last 5 Quarters
   Company's Profit Before Tax is increasing for last 5 Quarters
   Steady Net Margin in range of 15 to 20 for last 3 years
   Steady Growth in EPS for last four quarters
   Good Net Margin of 15.92% is achieved by the company
   Very Low Dividend Yield of 0 %
   Low Earning Yield of 2.50 %
Profitability Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Return On Equity 64.05 48.87 -23.04 % 15.28
Return On Asset 20.18 16.49 -9.11 % 5.71
Net Profit Margin 15.92 15.33 -8.76 % 20.07
Operating Profit Margin 17.87 18.30 -4.16 % 20.36
EBITDA Margin 52.25 16.75 -19.75 % 56.43


Highlights
Market Cap11970.13 M
Enterprise Value12017.64 M
Price/Book TTM25.17
Outstanding Share30983.40 K
Float/ Outstanding Share82.01%
Dividend Yield0 %
Share Holding
Guru Numbers
Price/Graham No6.20
Peter Lynch Ratio0.451
Piotroski F Score7.00
Altman Z Score7.73
Sloan Ratio-0.085
Peter Lynch Fair Value159.19


MEDP - Growth Highlights

Growth Analysis

   Short term positive trend in total sale and net profit
   Tremendous increasing trend in total sale last 3 year
   Quarterly sales in last 5 years is trending up
Growth Key Fields
Field TTM YoY Growth QoQ Growth
Revenue 1962.81 M 22.02 % 2.54 %
Gross Profit 549458 K 16.42 % 13.40 %
EBITDA 1025.60 M 2.07 % 12.28 %
Net Profit 312507 K 11.34 % 31.03 %
EPS 9.83 17.73 % NA


MEDP - Stability Highlights

Stability Analysis

   Tsr Stability Index - Good Score of 65.62
   Altman Z Score of 7.85 suggests good Stability
Stability Key Ratios
Ratio Latest FY Yoy Change MRQ
Debt to Equity Ratio 0.524 305.03 % 0.406
Cash Ratio 0.265 654.19 %
Quick Ratio 0.642 0 % 0.779
Shareholders Equity 33.74 18.09 %
Debt to EBITDA 0.982 498.32 %


Historical Valuation Ratios of Medpace Holdings Inc

Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Medpace Holdings Inc

Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Medpace Holdings Inc

Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Medpace Holdings Inc

Historical Solvency Ratios
Loading ...


Note : All Data Generated at the End of Trading Hours (EOD Data)